Form 4: Orgenesis Inc. Director Itzhak Vider Acquires Stock Options

Director Itzhak Vider of Orgenesis Inc. was granted 1,500 stock options on December 12, 2024, which vest in one year.

Summary

• Itzhak Vider, a director at Orgenesis Inc., received 1,500 stock options on December 12, 2024.
• These options have an exercise price of $0.98 per share.
• The options vest one year from the grant date, on December 12, 2025, contingent on continued service on the Board of Directors.
• The options expire on December 12, 2034.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock options to a director, which is generally viewed as a positive sign of alignment between management and shareholders. There is no indication of any negative or unusual activity.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting period encourages continued service on the Board of Directors.

Industry Context

This is a standard practice for incentivizing board members in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies.
• The vesting period of one year is fairly standard for such grants.
• The exercise price of $0.98 is typical for options granted at the current market price.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making.

Key Dates

Keywords

stock options, director, Orgenesis Inc., equity incentive plan, insider trading, beneficial ownership